Health Care & Life Sciences » Medical Equipment & Supplies | AdvanSource Biomaterials Corp.

AdvanSource Biomaterials Corp. | Income Statement

Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
2,626.00
2,574.00
3,181.00
2,284.00
2,918.00
Cost of Goods Sold (COGS) incl. D&A
1,006.00
928.00
1,080.00
853.00
799.00
Gross Income
1,620.00
1,646.00
2,101.00
1,431.00
2,119.00
SG&A Expense
1,827.00
1,578.00
1,697.00
1,572.00
1,938.00
EBIT
207.00
68.00
404.00
141.00
181.00
Non Operating Income/Expense
45.00
-
-
-
-
Interest Expense
359.00
386.00
371.00
368.00
383.00
Pretax Income
521.00
318.00
33.00
509.00
202.00
Consolidated Net Income
521.00
318.00
33.00
509.00
202.00
Net Income
521.00
318.00
33.00
509.00
202.00
Net Income After Extraordinaries
521.00
318.00
33.00
509.00
202.00
Net Income Available to Common
521.00
318.00
33.00
509.00
202.00
EPS (Basic)
0.02
0.01
0.00
0.02
0.01
Basic Shares Outstanding
21,491.00
21,491.00
21,491.00
21,491.00
21,491.00
EPS (Diluted)
0.02
0.01
0.00
0.02
0.01
Diluted Shares Outstanding
21,491.00
21,491.00
22,673.00
21,813.00
21,491.00
EBITDA
27.00
194.00
480.00
84.00
233.00

About AdvanSource Biomaterials

View Profile
Address
229 Andover Street
Wilmington Massachusetts 01887
United States
Employees -
Website http://www.advbiomaterials.com
Updated 07/08/2019
AdvanSource Biomaterials Corp. engages in the development of polymer materials which provide critical characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. Its products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.